8-K: Charlottes Web Extends $750,000 Loan to Joint Venture DeFloria

Charlottes Web Holdings, Inc. has provided a $750,000 promissory note to its joint venture, DeFloria Inc., with an initial interest rate of 13.25% and a maturity date tied to either December 31, 2026, or a future capital raise by DeFloria.

Summary

• Charlottes Web Holdings, Inc. (the Company) has issued a $750,000 promissory note to DeFloria Inc., a joint venture formed on April 6, 2023, with AJNA BioSciences PBC and a British American Tobacco PLC subsidiary.
• The loan carries an initial interest rate of 13.25% per annum, calculated on a non-compounded basis over 365 days, with the rate adjusting quarterly based on the Bank of England Base Rate plus 8.0 percentage points, capped at 14% per annum.
• The principal sum of $750,000 will be disbursed in five monthly tranches, starting with $375,000 upon execution of the Note on July 15, 2025, followed by four payments of $93,750 on August 1, September 1, October 1, and November 1, 2025.
• The Note matures on the later of December 31, 2026, or when DeFloria Inc. completes a bona fide financing transaction raising at least $10,000,000 from the sale of preferred units or similar securities.
• Proceeds from the loan are restricted for use only on costs and expenses approved by DeFloria's Board of Directors, as detailed in a redacted Exhibit A.
• In the event of a "Deemed Liquidation Event" for DeFloria, Charlottes Web is entitled to repayment of the outstanding principal and accrued interest, plus a 20% repayment premium.

Sentiment

Score: 6

Explanation: The loan provides necessary funding to a joint venture with a reasonable interest rate and some protective clauses (e.g., repayment premium). However, it also represents an outflow of capital and ties Charlottes Web's financial exposure to the success and future financing efforts of DeFloria, which introduces some risk and uncertainty, especially given the redacted use of funds.

Positives

• Provides necessary funding to DeFloria Inc., potentially supporting its operations and development.
• The loan carries a competitive interest rate (initial 13.25%, capped at 14%), providing a return on investment for Charlottes Web.
• The loan terms include a 20% repayment premium in case of a "Deemed Liquidation Event" for DeFloria, offering additional protection and potential upside for Charlottes Web.
• The loan is structured with clear payment tranches and maturity conditions, providing financial clarity.

Negatives

• Charlottes Web is extending capital to a joint venture, which carries inherent risks associated with the performance and financial stability of DeFloria Inc.
• The use of proceeds is restricted to "costs and expenses identified in the attached Exhibit A approved by the Company's Board of Directors," but Exhibit A is redacted, limiting transparency on specific expenditures.
• The maturity date is contingent on DeFloria's future capital raise, which introduces uncertainty regarding the exact repayment timeline.

Risks

• Default Risk: DeFloria Inc. may default on the loan if it fails to make payments within three business days of due date, materially breaches covenants or agreements, or experiences bankruptcy/insolvency events.
• Operational Risk: Termination of key agreements (Services Agreement, License Agreement, Supply Agreement) could trigger an event of default, indicating potential operational instability for DeFloria.
• Funding Risk: The maturity of the loan is tied to DeFloria's ability to raise at least $10,000,000 in future financing, and failure to do so by December 31, 2026, could impact repayment.
• Related Party Risk: As a loan to a joint venture, Charlottes Web is exposed to the operational and financial risks of DeFloria Inc., a related party.
• Regulatory/Legal Risk: DeFloria is covenanted to maintain legal activities and necessary authorizations, licenses, and permits; failure to do so could lead to default.

Future Outlook

The maturity of the loan is tied to DeFloria Inc.'s ability to raise at least $10,000,000 in future preferred unit financing, indicating an expectation or plan for DeFloria to seek significant external capital. DeFloria also has covenants to repay other obligations upon a $20,000,000 capital raise or by December 31, 2026.

Management Comments

• Charlottes Web, Inc. announced the formation of DeFloria Inc., a Delaware company, with AJNA BioSciences PBC and a subsidiary of British American Tobacco PLC.
• The Company entered into a promissory note, as lender, where the Company loaned $750,000 to DeFloria.

Industry Context

This transaction highlights continued investment and strategic partnerships within the evolving cannabis and CBD industry, particularly involving established players like British American Tobacco. The formation of joint ventures like DeFloria suggests a strategy to pool resources and expertise for specific market segments or product development, potentially in areas like biosciences or novel cannabis products, while navigating complex regulatory landscapes.

Corporate Governance

Related Party Transactions

• Charlottes Web Holdings, Inc. (the Company) has loaned $750,000 to DeFloria Inc., a joint venture in which Charlottes Web holds approximately 50% of the voting common units.
• DeFloria Inc. was formed with AJNA BioSciences PBC and a subsidiary of British American Tobacco PLC, making the loan an intercompany transaction within a strategic partnership.
• DeFloria Inc. has existing contractual obligations to Charlottes Web and its affiliates under the License Agreement, Services Agreement, and Supply Agreement, which are referenced in the loan covenants.

Stakeholder Impact

• Shareholders (Charlottes Web): The loan represents an investment in a joint venture, potentially supporting future growth and strategic objectives, but also exposes them to the financial risks of DeFloria Inc. The interest income could be a positive.
• Management (Charlottes Web): Responsible for overseeing the loan and the performance of the joint venture.
• DeFloria Inc. (Joint Venture): Receives crucial funding to support its operations and development, enabling it to pursue its strategic objectives.
• British American Tobacco PLC (BAT): As a preferred unit holder in DeFloria, BAT's investment is indirectly supported by this loan, potentially aiding the joint venture's progress.
• AJNA BioSciences PBC: As a common unit holder in DeFloria, AJNA's interest in the joint venture is also supported by this funding.

Next Steps

• DeFloria Inc. to receive subsequent loan payments of $93,750 on August 1, September 1, October 1, and November 1, 2025.
• DeFloria Inc. is expected to use the loan proceeds for approved costs and expenses.
• DeFloria Inc. is expected to seek a bona fide financing transaction to raise at least $10,000,000, which would trigger the maturity of the promissory note.
• DeFloria Inc. is expected to seek a bona fide financing transaction to raise at least $20,000,000 to repay obligations under other agreements.
• DeFloria Inc. must maintain compliance with its covenants, including corporate governance, legal activities, and insurance.

Key Dates

Recommendation

Keywords

Charlottes Web Holdings, DeFloria Inc., Promissory Note, Loan, Joint Venture, SEC Filing, 8-K, Corporate Finance, Intercompany Loan, Cannabis Industry, CBD, British American Tobacco, AJNA BioSciences, Related Party Transaction, Debt Financing